No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CDLX240816C4000
- 4.94
- 0.000.00%
15min DelayTrading Jul 17 12:13 ET
0.00High0.00Low
0.00Open4.94Pre Close0 Volume10 Open Interest4.00Strike Price0.00Turnover217.34%IV-2.40%PremiumAug 16, 2024Expiry Date5.16Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9610Delta0.0163Gamma1.51Leverage Ratio-0.0093Theta0.0024Rho1.45Eff Leverage0.0020Vega
Intraday
- 5D
- Daily
News
Express News | Cardlytics Inc : BofA Global Research Reinstates Coverage With Neutral Rating; Price Objective $11
Cardlytics Price Target Announced at $11.00/Share by B of A Securities
Express News | B of A Securities Reinstates Neutral on Cardlytics, Announces $11 Price Target
BofA Securities Initiates Cardlytics(CDLX.US) With Hold Rating, Announces Target Price $11
Express News | Cardlytics Inc : Northland Capital Initiates Coverage With Outperform Rating; Target Price $14
Cardlytics Initiated at Outperform by Northland Capital Markets
Comments
$Cardlytics(CDLX.US$ DEMON NET 🤔
$Cardlytics(CDLX.US$ 15 tonight!!
Cardlytics' unique position with access to large datasets could be a boon as AI adoption progresses. Its acquisition of Dosh is expected to strengthen its position in the underbanked category. CDLX stock is deemed a 'Strong Buy'.
4
1
$Cardlytics(CDLX.US$ Clifford Sosin, 10% Owner, around March 15, 2024, executed a purchase for 661,715 shares in Cardlytics (CDLX) for $8,963,859. Following the Form 4 filing with the SEC, Sosin has control over a total of 6,023,676 shares of the company, with 6,023,676 shares controlled indirectly.
Read more